25 XP   0   0   10

Bioqual Inc
Buy, Hold or Sell?

Let's analyse Bioqual together

PenkeI guess you are interested in Bioqual Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioqual Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.

Quick analysis of Bioqual (30 sec.)










What can you expect buying and holding a share of Bioqual? (30 sec.)

How much money do you get?

How much money do you get?
$0.50
When do you have the money?
1 year
How often do you get paid?
77.8%

What is your share worth?

Current worth
$43.10
Expected worth in 1 year
$42.09
How sure are you?
70.4%

+ What do you gain per year?

Total Gains per Share
$-0.51
Return On Investment
-0.7%

For what price can you sell your share?

Current Price per Share
$75.00
Expected price per share
$72.00 - $80.00
How sure are you?
50%

1. Valuation of Bioqual (5 min.)




Live pricePrice per Share (EOD)

$75.00

Intrinsic Value Per Share

$121.09 - $145.05

Total Value Per Share

$164.19 - $188.15

2. Growth of Bioqual (5 min.)




Is Bioqual growing?

Current yearPrevious yearGrowGrow %
How rich?$38.5m$32.5m$5.6m14.8%

How much money is Bioqual making?

Current yearPrevious yearGrowGrow %
Making money-$114.4k$1.3m-$1.4m-1,284.5%
Net Profit Margin-0.9%4.1%--

How much money comes from the company's main activities?

3. Financial Health of Bioqual (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#90 / 146

Most Revenue
#92 / 146

Most Profit
#69 / 146

What can you expect buying and holding a share of Bioqual? (5 min.)

Welcome investor! Bioqual's management wants to use your money to grow the business. In return you get a share of Bioqual.

What can you expect buying and holding a share of Bioqual?

First you should know what it really means to hold a share of Bioqual. And how you can make/lose money.

Speculation

The Price per Share of Bioqual is $75.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioqual.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioqual, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $43.10. Based on the TTM, the Book Value Change Per Share is $-0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $5.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioqual.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.540.7%-0.13-0.2%1.381.8%0.941.3%0.891.2%
Usd Book Value Change Per Share0.040.1%-0.25-0.3%5.116.8%0.881.2%1.161.5%
Usd Dividend Per Share0.500.7%0.130.2%0.500.7%0.610.8%0.580.8%
Usd Total Gains Per Share0.540.7%-0.13-0.2%5.617.5%1.492.0%1.742.3%
Usd Price Per Share64.00-77.25-76.50-66.38-56.95-
Price to Earnings Ratio29.53-0.27-15.82-11.75-11.30-
Price-to-Total Gains Ratio118.11-1.07-26.34-43.37-32.93-
Price to Book Ratio1.48-1.81-2.52-2.36-2.18-
Price-to-Total Gains Ratio118.11-1.07-26.34-43.37-32.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share75
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.61
Usd Book Value Change Per Share-0.250.88
Usd Total Gains Per Share-0.131.49
Gains per Quarter (13 shares)-1.6619.31
Gains per Year (13 shares)-6.6477.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17-13-17324667
213-26-246391144
320-39-3195137221
426-53-38126183298
533-66-45158228375
639-79-52190274452
746-92-59221319529
852-105-66253365606
959-118-73284411683
1065-131-80316456760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%18.02.00.090.0%25.02.00.092.6%48.03.00.094.1%
Book Value Change Per Share2.02.00.050.0%4.02.06.033.3%6.03.011.030.0%10.06.011.037.0%30.010.011.058.8%
Dividend per Share1.00.03.025.0%7.00.05.058.3%14.00.06.070.0%21.00.06.077.8%33.00.018.064.7%
Total Gains per Share2.02.00.050.0%8.02.02.066.7%14.03.03.070.0%19.05.03.070.4%39.09.03.076.5%

Fundamentals of Bioqual

About Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Fundamental data was last updated by Penke on 2024-03-29 02:56:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bioqual Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioqual earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 3.1% means that $0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioqual Inc:

  • The MRQ is 3.1%. The company is making a profit. +1
  • The TTM is -0.9%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ3.1%TTM-0.9%+4.0%
TTM-0.9%YOY4.1%-5.0%
TTM-0.9%5Y2.0%-2.9%
5Y2.0%10Y4.0%-1.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%-7.2%+10.3%
TTM-0.9%-6.3%+5.4%
YOY4.1%1.3%+2.8%
5Y2.0%-3.1%+5.1%
10Y4.0%-1.4%+5.4%
1.1.2. Return on Assets

Shows how efficient Bioqual is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • 0.8% Return on Assets means that Bioqual generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioqual Inc:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.8%TTM-0.2%+1.0%
TTM-0.2%YOY2.5%-2.7%
TTM-0.2%5Y2.1%-2.3%
5Y2.1%10Y2.5%-0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-1.5%+2.3%
TTM-0.2%-1.2%+1.0%
YOY2.5%-0.6%+3.1%
5Y2.1%-0.6%+2.7%
10Y2.5%-0.9%+3.4%
1.1.3. Return on Equity

Shows how efficient Bioqual is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • 1.3% Return on Equity means Bioqual generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioqual Inc:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.3%TTM-0.3%+1.6%
TTM-0.3%YOY4.4%-4.7%
TTM-0.3%5Y3.5%-3.8%
5Y3.5%10Y3.7%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%-0.5%+1.8%
TTM-0.3%--0.3%
YOY4.4%0.3%+4.1%
5Y3.5%-1.5%+5.0%
10Y3.7%-2.5%+6.2%

1.2. Operating Efficiency of Bioqual Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioqual is operating .

  • Measures how much profit Bioqual makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • An Operating Margin of 3.5% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioqual Inc:

  • The MRQ is 3.5%. The company is operating less efficient.
  • The TTM is -1.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ3.5%TTM-1.8%+5.3%
TTM-1.8%YOY9.0%-10.8%
TTM-1.8%5Y3.3%-5.0%
5Y3.3%10Y6.0%-2.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%-5.2%+8.7%
TTM-1.8%-3.8%+2.0%
YOY9.0%4.4%+4.6%
5Y3.3%1.6%+1.7%
10Y6.0%-2.0%+8.0%
1.2.2. Operating Ratio

Measures how efficient Bioqual is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioqual Inc:

  • The MRQ is 0.965. The company is less efficient in keeping operating costs low.
  • The TTM is 1.018. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.965TTM1.018-0.053
TTM1.018YOY0.442+0.576
TTM1.0185Y0.543+0.475
5Y0.54310Y0.811-0.269
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9651.302-0.337
TTM1.0181.303-0.285
YOY0.4421.236-0.794
5Y0.5431.254-0.711
10Y0.8111.238-0.427

1.3. Liquidity of Bioqual Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioqual is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.20 means the company has $4.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioqual Inc:

  • The MRQ is 4.204. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.065. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.204TTM4.065+0.139
TTM4.065YOY3.591+0.474
TTM4.0655Y4.054+0.011
5Y4.05410Y4.731-0.677
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2042.248+1.956
TTM4.0652.426+1.639
YOY3.5912.753+0.838
5Y4.0542.989+1.065
10Y4.7313.000+1.731
1.3.2. Quick Ratio

Measures if Bioqual is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.94 means the company can pay off $3.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioqual Inc:

  • The MRQ is 3.936. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.726. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.936TTM3.726+0.211
TTM3.726YOY3.204+0.521
TTM3.7265Y2.981+0.745
5Y2.98110Y3.068-0.087
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9361.284+2.652
TTM3.7261.357+2.369
YOY3.2041.563+1.641
5Y2.9811.952+1.029
10Y3.0682.127+0.941

1.4. Solvency of Bioqual Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioqual assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioqual to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.35 means that Bioqual assets are financed with 35.1% credit (debt) and the remaining percentage (100% - 35.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioqual Inc:

  • The MRQ is 0.351. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.373. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.351TTM0.373-0.021
TTM0.373YOY0.413-0.040
TTM0.3735Y0.388-0.015
5Y0.38810Y0.325+0.062
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3510.425-0.074
TTM0.3730.411-0.038
YOY0.4130.393+0.020
5Y0.3880.450-0.062
10Y0.3250.448-0.123
1.4.2. Debt to Equity Ratio

Measures if Bioqual is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 54.2% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioqual Inc:

  • The MRQ is 0.542. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.595. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.542TTM0.595-0.053
TTM0.595YOY0.705-0.111
TTM0.5955Y0.658-0.064
5Y0.65810Y0.532+0.126
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5420.606-0.064
TTM0.5950.571+0.024
YOY0.7050.606+0.099
5Y0.6580.637+0.021
10Y0.5320.730-0.198

2. Market Valuation of Bioqual Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioqual generates.

  • Above 15 is considered overpriced but always compare Bioqual to the Diagnostics & Research industry mean.
  • A PE ratio of 29.53 means the investor is paying $29.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioqual Inc:

  • The EOD is 34.602. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.527. Based on the earnings, the company is overpriced. -1
  • The TTM is 0.270. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD34.602MRQ29.527+5.075
MRQ29.527TTM0.270+29.258
TTM0.270YOY15.823-15.553
TTM0.2705Y11.746-11.477
5Y11.74610Y11.296+0.451
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD34.602-0.202+34.804
MRQ29.527-0.402+29.929
TTM0.270-0.119+0.389
YOY15.823-0.003+15.826
5Y11.7461.941+9.805
10Y11.2965.487+5.809
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioqual Inc:

  • The EOD is 4.018. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.429. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.399. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.018MRQ3.429+0.589
MRQ3.429TTM0.399+3.030
TTM0.399YOY279.031-278.631
TTM0.3995Y64.893-64.493
5Y64.89310Y49.073+15.820
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD4.018-0.179+4.197
MRQ3.429-0.417+3.846
TTM0.399-1.057+1.456
YOY279.031-1.918+280.949
5Y64.893-2.492+67.385
10Y49.073-2.398+51.471
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioqual is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.48 means the investor is paying $1.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioqual Inc:

  • The EOD is 1.740. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.485. Based on the equity, the company is underpriced. +1
  • The TTM is 1.807. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.740MRQ1.485+0.255
MRQ1.485TTM1.807-0.322
TTM1.807YOY2.523-0.715
TTM1.8075Y2.365-0.557
5Y2.36510Y2.177+0.187
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.7401.910-0.170
MRQ1.4852.459-0.974
TTM1.8072.236-0.429
YOY2.5233.239-0.716
5Y2.3653.450-1.085
10Y2.1774.118-1.941
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bioqual Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.042-0.253+704%5.115-99%0.878-95%1.156-96%
Book Value Per Share--43.10142.763+1%33.772+28%29.814+45%27.312+58%
Current Ratio--4.2044.065+3%3.591+17%4.054+4%4.731-11%
Debt To Asset Ratio--0.3510.373-6%0.413-15%0.388-9%0.325+8%
Debt To Equity Ratio--0.5420.595-9%0.705-23%0.658-18%0.532+2%
Dividend Per Share--0.5000.125+300%0.500+0%0.608-18%0.583-14%
Eps--0.542-0.128+124%1.375-61%0.938-42%0.893-39%
Free Cash Flow Per Share--4.6662.425+92%-0.553+112%0.374+1147%0.232+1914%
Free Cash Flow To Equity Per Share--4.1662.300+81%-1.053+125%-0.203+105%-0.260+106%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.963+4%
Intrinsic Value_10Y_max--145.053--------
Intrinsic Value_10Y_min--121.090--------
Intrinsic Value_1Y_max--3.764--------
Intrinsic Value_1Y_min--3.691--------
Intrinsic Value_3Y_max--19.518--------
Intrinsic Value_3Y_min--18.468--------
Intrinsic Value_5Y_max--45.169--------
Intrinsic Value_5Y_min--41.218--------
Market Cap67081200.000+15%57242624.00069093636.000-17%76430397.000-25%67719738.800-15%59113404.259-3%
Net Profit Margin--0.031-0.009+130%0.041-26%0.020+50%0.040-23%
Operating Margin--0.035-0.018+150%0.090-61%0.033+9%0.060-40%
Operating Ratio--0.9651.018-5%0.442+118%0.543+78%0.811+19%
Pb Ratio1.740+15%1.4851.807-18%2.523-41%2.365-37%2.177-32%
Pe Ratio34.602+15%29.5270.270+10851%15.823+87%11.746+151%11.296+161%
Price Per Share75.000+15%64.00077.250-17%76.500-16%66.382-4%56.948+12%
Price To Free Cash Flow Ratio4.018+15%3.4290.399+758%279.031-99%64.893-95%49.073-93%
Price To Total Gains Ratio138.409+15%118.1091.069+10948%26.336+348%43.368+172%32.934+259%
Quick Ratio--3.9363.726+6%3.204+23%2.981+32%3.068+28%
Return On Assets--0.008-0.002+122%0.025-68%0.021-61%0.025-67%
Return On Equity--0.013-0.003+125%0.044-71%0.035-64%0.037-66%
Total Gains Per Share--0.542-0.128+124%5.615-90%1.485-64%1.740-69%
Usd Book Value--38550553.00038248259.250+1%32573855.750+18%29508498.900+31%27305308.481+41%
Usd Book Value Change Per Share--0.042-0.253+704%5.115-99%0.878-95%1.156-96%
Usd Book Value Per Share--43.10142.763+1%33.772+28%29.814+45%27.312+58%
Usd Dividend Per Share--0.5000.125+300%0.500+0%0.608-18%0.583-14%
Usd Eps--0.542-0.128+124%1.375-61%0.938-42%0.893-39%
Usd Free Cash Flow--4173355.0002168601.750+92%-641736.750+115%295074.350+1314%198962.630+1998%
Usd Free Cash Flow Per Share--4.6662.425+92%-0.553+112%0.374+1147%0.232+1914%
Usd Free Cash Flow To Equity Per Share--4.1662.300+81%-1.053+125%-0.203+105%-0.260+106%
Usd Market Cap67081200.000+15%57242624.00069093636.000-17%76430397.000-25%67719738.800-15%59113404.259-3%
Usd Price Per Share75.000+15%64.00077.250-17%76.500-16%66.382-4%56.948+12%
Usd Profit--484661.000-114425.500+124%1355378.750-64%938753.600-48%916448.926-47%
Usd Revenue--15869404.00015406107.000+3%8121925.500+95%6282186.900+153%6978860.259+127%
Usd Total Gains Per Share--0.542-0.128+124%5.615-90%1.485-64%1.740-69%
 EOD+4 -4MRQTTM+30 -5YOY+19 -165Y+20 -1610Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Bioqual Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.602
Price to Book Ratio (EOD)Between0-11.740
Net Profit Margin (MRQ)Greater than00.031
Operating Margin (MRQ)Greater than00.035
Quick Ratio (MRQ)Greater than13.936
Current Ratio (MRQ)Greater than14.204
Debt to Asset Ratio (MRQ)Less than10.351
Debt to Equity Ratio (MRQ)Less than10.542
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.008
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.385
Ma 20Greater thanMa 5079.000
Ma 50Greater thanMa 10075.260
Ma 100Greater thanMa 20071.750
OpenGreater thanClose75.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets59,427
Total Liabilities20,876
Total Stockholder Equity38,551
 As reported
Total Liabilities 20,876
Total Stockholder Equity+ 38,551
Total Assets = 59,427

Assets

Total Assets59,427
Total Current Assets30,921
Long-term Assets28,506
Total Current Assets
Cash And Cash Equivalents 10,162
Net Receivables 18,791
Other Current Assets 1,969
Total Current Assets  (as reported)30,921
Total Current Assets  (calculated)30,921
+/-0
Long-term Assets
Property Plant Equipment 27,459
Goodwill 1,028
Long-term Assets Other 19
Long-term Assets  (as reported)28,506
Long-term Assets  (calculated)28,506
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,356
Long-term Liabilities13,521
Total Stockholder Equity38,551
Total Current Liabilities
Short-term Debt 3,476
Accounts payable 1,499
Other Current Liabilities 1,933
Total Current Liabilities  (as reported)7,356
Total Current Liabilities  (calculated)6,908
+/- 447
Long-term Liabilities
Long-term Liabilities  (as reported)13,521
Long-term Liabilities  (calculated)0
+/- 13,521
Total Stockholder Equity
Common Stock16
Retained Earnings 32,211
Other Stockholders Equity 6,324
Total Stockholder Equity (as reported)38,551
Total Stockholder Equity (calculated)38,551
+/-0
Other
Cash and Short Term Investments 10,162
Common Stock Shares Outstanding 894
Current Deferred Revenue447
Liabilities and Stockholders Equity 59,427
Net Debt 6,595
Net Working Capital 23,566
Short Long Term Debt Total 16,757



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-30
> Total Assets 
4,948
4,894
5,326
4,838
4,748
5,010
4,874
5,036
5,013
5,050
0
0
0
8,688
9,034
8,786
9,411
10,152
0
0
12,233
0
11,840
11,861
13,297
13,998
22,796
23,024
23,119
24,124
26,305
26,667
26,330
27,580
28,310
45,664
0
0
0
0
0
0
0
0
0
0
0
65,284
64,034
61,738
61,317
61,491
59,427
59,42761,49161,31761,73864,03465,2840000000000045,66428,31027,58026,33026,66726,30524,12423,11923,02422,79613,99813,29711,86111,840012,2330010,1529,4118,7869,0348,6880005,0505,0135,0364,8745,0104,7484,8385,3264,8944,948
   > Total Current Assets 
2,130
2,040
2,480
2,106
2,130
2,236
2,256
2,481
2,529
2,651
0
0
0
4,947
5,067
4,637
5,348
6,153
0
0
8,545
0
8,501
8,651
9,979
10,867
18,013
17,640
17,433
18,064
20,253
20,485
19,919
20,826
21,271
22,138
24,694
24,740
26,255
26,672
27,522
26,391
29,322
29,082
28,746
29,666
31,728
31,034
30,385
29,603
29,940
31,577
30,921
30,92131,57729,94029,60330,38531,03431,72829,66628,74629,08229,32226,39127,52226,67226,25524,74024,69422,13821,27120,82619,91920,48520,25318,06417,43317,64018,01310,8679,9798,6518,50108,545006,1535,3484,6375,0674,9470002,6512,5292,4812,2562,2362,1302,1062,4802,0402,130
       Cash And Cash Equivalents 
70
71
72
73
74
75
76
77
77
78
0
0
0
2,251
281
446
752
2,794
0
0
3,153
0
2,004
1,410
2,719
3,760
9,288
8,129
7,967
8,451
10,161
10,347
8,378
8,426
9,208
8,340
0
0
0
0
0
0
0
0
0
0
0
2,199
1,933
4,364
7,279
6,436
10,162
10,1626,4367,2794,3641,9332,199000000000008,3409,2088,4268,37810,34710,1618,4517,9678,1299,2883,7602,7191,4102,00403,153002,7947524462812,25100078777776757473727170
       Net Receivables 
1,564
1,545
1,970
1,577
1,654
1,816
1,739
1,935
2,060
2,226
0
0
0
2,514
4,479
3,903
4,307
2,894
0
0
5,218
0
6,155
7,015
7,112
6,730
8,354
9,061
9,012
9,275
9,693
9,295
10,584
11,597
11,529
12,601
17,881
14,015
14,638
19,414
18,479
19,537
20,108
19,670
21,006
24,830
26,764
26,427
26,688
21,517
21,318
22,183
18,791
18,79122,18321,31821,51726,68826,42726,76424,83021,00619,67020,10819,53718,47919,41414,63814,01517,88112,60111,52911,59710,5849,2959,6939,2759,0129,0618,3546,7307,1127,0156,15505,218002,8944,3073,9034,4792,5140002,2262,0601,9351,7391,8161,6541,5771,9701,5451,564
       Inventory 
298
257
226
251
243
222
181
160
158
134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000134158160181222243251226257298
       Other Current Assets 
197
167
212
204
158
122
260
309
233
213
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112
450
453
338
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,408
1,764
3,722
1,343
2,958
1,969
1,9692,9581,3433,7221,7642,408000000000000000003384534501120000000000000000213233309260122158204212167197
   > Long-term Assets 
2,818
2,853
2,846
2,732
2,618
2,773
2,618
2,555
2,484
2,400
0
0
0
3,741
3,967
4,149
4,063
4,000
0
0
3,689
0
3,339
3,210
3,318
3,132
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,250
33,649
32,136
31,377
29,915
28,506
28,50629,91531,37732,13633,64934,2500000000000000000000003,1323,3183,2103,33903,689004,0004,0634,1493,9673,7410002,4002,4842,5552,6182,7732,6182,7322,8462,8532,818
       Property Plant Equipment 
1,504
1,617
1,607
1,597
1,507
1,413
1,413
1,466
1,516
1,527
0
0
0
3,136
3,362
3,544
3,458
3,344
0
0
2,895
0
2,545
2,416
2,482
2,295
2,948
3,476
3,780
4,157
4,288
4,421
4,653
4,999
5,294
21,784
21,385
21,022
21,496
22,236
21,997
22,125
22,958
23,392
31,645
31,171
30,586
33,203
32,602
31,089
30,349
28,868
27,459
27,45928,86830,34931,08932,60233,20330,58631,17131,64523,39222,95822,12521,99722,23621,49621,02221,38521,7845,2944,9994,6534,4214,2884,1573,7803,4762,9482,2952,4822,4162,54502,895003,3443,4583,5443,3623,1360001,5271,5161,4661,4131,4131,5071,5971,6071,6171,504
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
0
0
0
0
0
0
0
0
0
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,0281,0281,0281,0281,0281,028000000000001,0281,0281,0281,0281,0281,0281,0281,0281,0281,02800000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
664
548
427
401
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000401427548664000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37
34
32
29
26
24
21
19
16
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001416192124262932343700000000000000000000000000
       Long-term Assets Other 
714
636
741
638
613
863
1,006
890
769
763
0
0
0
605
605
605
605
656
0
0
794
0
794
794
836
836
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
19
19
-31,377
19
19
1919-31,3771919190000000000000000000008368367947940794006566056056056050007637698901,006863613638741636714
> Total Liabilities 
1,452
1,384
1,758
1,249
1,086
1,300
1,045
1,143
1,045
995
0
0
0
2,041
2,103
1,619
1,890
2,510
0
0
2,070
0
1,725
1,711
2,924
3,354
3,881
3,323
3,226
3,427
4,255
3,779
3,402
4,182
3,746
19,773
0
0
0
0
0
0
0
0
0
0
0
26,228
24,578
23,422
23,703
22,978
20,876
20,87622,97823,70323,42224,57826,2280000000000019,7733,7464,1823,4023,7794,2553,4273,2263,3233,8813,3542,9241,7111,72502,070002,5101,8901,6192,1032,0410009951,0451,1431,0451,3001,0861,2491,7581,3841,452
   > Total Current Liabilities 
1,433
1,379
1,568
1,086
946
1,204
962
1,089
1,023
985
0
0
0
1,573
1,661
1,194
1,465
2,181
0
0
1,491
0
1,192
1,197
2,477
2,898
3,100
2,601
2,531
2,748
3,464
2,956
2,548
3,304
2,777
5,083
7,290
7,047
7,682
6,635
7,585
6,446
8,517
8,056
9,502
9,754
9,765
8,280
7,026
6,871
8,297
7,626
7,356
7,3567,6268,2976,8717,0268,2809,7659,7549,5028,0568,5176,4467,5856,6357,6827,0477,2905,0832,7773,3042,5482,9563,4642,7482,5312,6013,1002,8982,4771,1971,19201,491002,1811,4651,1941,6611,5730009851,0231,0899621,2049461,0861,5681,3791,433
       Short-term Debt 
898
891
811
475
387
645
302
379
479
364
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
567
489
317
301
250
168
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,539
3,071
3,196
3,442
2,598
3,476
3,4762,5983,4423,1963,0713,5390000000000000086168250301317489567000000000003160000364479379302645387475811891898
       Short Long Term Debt 
0
0
0
0
0
0
302
379
479
364
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
567
489
317
301
250
168
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000861682503013174895670000000000000000364479379302000000
       Accounts payable 
157
193
201
208
117
209
168
326
210
197
0
0
0
569
439
436
392
409
0
0
401
0
340
482
599
581
1,241
891
1,305
1,177
1,804
1,556
1,017
1,900
1,312
909
1,265
1,764
2,476
1,667
2,233
864
2,108
1,758
3,123
2,923
3,289
1,543
1,515
1,119
1,594
3,077
1,499
1,4993,0771,5941,1191,5151,5433,2892,9233,1231,7582,1088642,2331,6672,4761,7641,2659091,3121,9001,0171,5561,8041,1771,3058911,241581599482340040100409392436439569000197210326168209117208201193157
       Other Current Liabilities 
377
295
555
403
442
350
492
384
334
424
0
0
0
1,004
906
758
1,073
1,771
0
0
931
0
626
635
1,016
582
209
645
151
229
365
640
621
292
306
721
2,573
1,553
828
1,268
1,081
1,116
958
1,919
1,545
1,912
1,165
1,331
1,764
2,029
2,304
1,242
1,933
1,9331,2422,3042,0291,7641,3311,1651,9121,5451,9199581,1161,0811,2688281,5532,5737213062926216403652291516452095821,0166356260931001,7711,0737589061,004000424334384492350442403555295377
   > Long-term Liabilities 
19
5
190
163
140
96
83
53
22
10
0
0
0
467
442
426
425
330
0
0
579
0
533
514
447
456
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,948
17,552
16,551
15,406
15,352
13,521
13,52115,35215,40616,55117,55217,9480000000000000000000004564475145330579003304254264424670001022538396140163190519
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
791
823
853
878
969
208
208
208
413
413
413
413
58
58
58
58
251
251
251
251
240
0
0
002402512512512515858585841341341341320820820896987885382379164960254953100000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000064960254953100000000000000000000000000
> Total Stockholder Equity
3,496
3,510
3,568
3,589
3,662
3,709
3,829
3,893
3,968
4,055
0
0
0
6,648
6,931
7,166
7,521
7,642
0
0
10,163
0
10,115
10,150
10,373
10,644
18,915
19,702
19,893
20,697
22,050
22,888
22,929
23,398
24,564
25,892
0
0
0
0
0
0
0
0
0
0
0
39,056
39,455
38,316
37,614
38,513
38,551
38,55138,51337,61438,31639,45539,0560000000000025,89224,56423,39822,92922,88822,05020,69719,89319,70218,91510,64410,37310,15010,115010,163007,6427,5217,1666,9316,6480004,0553,9683,8933,8293,7093,6623,5893,5683,5103,496
   Common Stock
16
16
16
16
16
16
16
16
16
16
0
0
0
16
16
16
16
16
0
0
16
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
1616161616161616161616161616161616161616161616161616161616161601600161616161600016161616161616161616
   Retained Earnings 
-3,292
-3,282
-3,230
-3,209
-3,137
-3,090
-2,971
-2,911
-2,837
-2,749
0
0
0
282
564
800
1,151
1,260
0
0
3,800
0
3,752
3,834
4,058
4,329
12,615
13,402
13,593
14,392
15,741
16,576
16,614
17,079
18,242
19,567
19,833
20,553
21,847
23,614
24,091
25,067
27,190
28,567
28,589
29,445
31,333
32,716
33,116
31,976
31,274
32,173
32,211
32,21132,17331,27431,97633,11632,71631,33329,44528,58928,56727,19025,06724,09123,61421,84720,55319,83319,56718,24217,07916,61416,57615,74114,39213,59313,40212,6154,3294,0583,8343,75203,800001,2601,151800564282000-2,749-2,837-2,911-2,971-3,090-3,137-3,209-3,230-3,282-3,292
   Capital Surplus 00000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000-691-690-690-692-692-692-693-693-6990
   Other Stockholders Equity 
6,772
6,776
6,782
6,782
6,783
6,783
6,785
6,788
6,788
6,788
0
0
0
6,350
6,351
6,351
6,354
6,366
0
0
6,347
0
6,347
6,299
6,299
6,299
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,324
6,324
6,324
6,324
6,324
6,324
6,3246,3246,3246,3246,3246,3240000000000000000000006,2996,2996,2996,34706,347006,3666,3546,3516,3516,3500006,7886,7886,7886,7856,7836,7836,7826,7826,7766,772



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-05-31)

Gross Profit (+$)
totalRevenue62,664
Cost of Revenue-54,019
Gross Profit8,6458,645
 
Operating Income (+$)
Gross Profit8,645
Operating Expense-7,542
Operating Income1,1031,103
 
Operating Expense (+$)
Research Development806
Selling General Administrative7,542
Selling And Marketing Expenses0
Operating Expense7,5428,348
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income1,103
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,1331,073
EBIT - interestExpense = 1,103
1,133
836
Interest Expense0
Earnings Before Interest and Taxes (EBIT)1,1031,133
Earnings Before Interest and Taxes (EBITDA)6,937
 
After tax Income (+$)
Income Before Tax1,133
Tax Provision-0
Net Income From Continuing Ops01,133
Net Income836
Net Income Applicable To Common Shares836
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses61,561
Total Other Income/Expenses Net300
 

Technical Analysis of Bioqual
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioqual. The general trend of Bioqual is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioqual's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioqual Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 80.00 < 80.00 < 80.00.

The bearish price targets are: 72.00 > 72.00 > 72.00.

Tweet this
Bioqual Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioqual Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioqual Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioqual Inc. The current macd is 0.02717239.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioqual price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bioqual. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bioqual price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bioqual Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioqual Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioqual Inc. The current adx is 58.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bioqual shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Bioqual Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioqual Inc. The current sar is 79.80.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bioqual Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioqual Inc. The current rsi is 29.38. The current phase is Oversold in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bull market: Short-term excessive selling, potential for rebound. Consider buying at a perceived discount, watch for reversal signs. +1
Bioqual Inc Daily Relative Strength Index (RSI) ChartBioqual Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioqual Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioqual price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bioqual Inc Daily Stochastic Oscillator ChartBioqual Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioqual Inc. The current cci is -173.85057471.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bioqual Inc Daily Commodity Channel Index (CCI) ChartBioqual Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioqual Inc. The current cmo is -70.9375925.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bioqual Inc Daily Chande Momentum Oscillator (CMO) ChartBioqual Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioqual Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bioqual Inc Daily Williams %R ChartBioqual Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bioqual Inc.

Bioqual Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioqual Inc. The current atr is 0.43545551.

Bioqual Inc Daily Average True Range (ATR) ChartBioqual Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioqual Inc. The current obv is -11,151.

Bioqual Inc Daily On-Balance Volume (OBV) ChartBioqual Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioqual Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bioqual Inc Daily Money Flow Index (MFI) ChartBioqual Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioqual Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Bioqual Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.385
Ma 20Greater thanMa 5079.000
Ma 50Greater thanMa 10075.260
Ma 100Greater thanMa 20071.750
OpenGreater thanClose75.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bioqual with someone you think should read this too:
  • Are you bullish or bearish on Bioqual? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioqual? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bioqual Inc.

Receive notifications about Bioqual Inc in your mailbox!